Brief: Synact Pharma Q2 Pre-Tax Loss Narrows To SEK 7.3 Million
30/08/2019 08:17
Aug 30 (Reuters) - SynAct Pharma AB SYNACT.TE :
* Q2 LOSS AFTER FINANCIAL ITEMS SEK 7.3 MILLION VERSUS LOSS SEK 9.9 MILLION YEAR AGO
Source text for Eikon: ID:nNDL4D6n8C
Further company coverage: SYNACT.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development